why choose us

First received: November 30, 2023

Clinical Trial: A Controlled Study on Pain Management With Injection of Botulinum Toxin for Glabellar Line Correction

Study Status: Completed

Recruit Status: RECRUITING

Condition: Injection Site Discomfort

Study Type: INTERVENTIONAL


Official Title: An Open-label, Randomized, Split-face, Controlled Study on Pain Management With Injection of Botulinum Toxin for Glabellar Line Correction

Brief Summary: This is an open-label, single-center, randomized, split-face, controlled study to assess the effect of comfort intervention on pain during treatment injection compared against non-comfort intervention.

Read more